Delivery Order SPE2DR25D3504-SPE2DR26F7CS9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,577.56 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 27, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of January 28, 2026. The contract employs firm fixed-price pricing and was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as...
- The Defense Logistics Agency (DLA) awarded a $62,044.86 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, with an ultimate completion date of January 8, 2026. The contract was competitively awarded with no set-aside designation and utilizes firm fixed-price pricing. Performance will take place at the awardee's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of...
- The Defense Logistics Agency awarded a $7,959.80 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 26, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of January 27, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. The place of performance is located in Conshohocken, Pennsylvania, where the vendor maintains its corporate office....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,193.97 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 26, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This is a firm fixed-price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility and an ultimate completion date of January 27, 2026. The award represents a task order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $4,108.44 delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 13, 2026, for the supply of HUMIRA Pen 40 mg/0.8 mL. This competitive, non-set-aside contract utilizes firm fixed-price pricing and is scheduled for completion by January 14, 2026. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate headquarters. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,300.82 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 21, 2026, for the supply of Humira Pen 40 mg/0.8 mL. This firm fixed-price delivery order, with an ultimate completion date of January 22, 2026, was issued on a non-competitive basis with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $48.4K delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 9, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the company's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical...
- On January 23, 2026, the Defense Logistics Agency awarded a delivery order valued at $118,075.85 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This firm fixed-price, non-set-aside contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $1,591.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, with an ultimate completion date of January 16, 2026. The contract covers the delivery of HUMIRA (CF) Pen 80 mg/0.8 mL, a pharmaceutical product to be performed at the company's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation, reflecting the vendor's established capability to...
- The Defense Logistics Agency awarded a $20,770.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 27, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. The contract, which is expected to be completed by January 28, 2026, was awarded on a non-set-aside basis through open competition. Performance will be conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7CS9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,202.52 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 27, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This is a firm fixed-price delivery order with no set-aside designation, executed on a fully competitive basis. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 28, 2026. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle enabling the company to deliver a broad range of medications, vaccines, medical devices, and specialty healthcare commodities to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen has demonstrated substantial capability in fulfilling federal medical procurement requirements across multiple therapeutic domains through both small-value transactions and substantial orders under this prime contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 1/26/26 |